Related content

Oral contraceptives: Vertigo (first report with ethinylestradiol/drospirenone, ethinylestradiol/levonorgestrel and ethinylestradiol/gestodene): 10 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1106, 2006-01 ,pp. : 16-17

Adis International

Access to resources Recommend Favorite

Ethinylestradiol-containing oral contraceptives decrease CYP2C19 activity

By  

Inpharma, Vol. 1, Iss. 1407, 2003-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

Effects of Oral Contraceptives Containing Ethinylestradiol with Either Drospirenone or Levonorgestrel on Various Parameters Associated with Well-Being in Healthy Women: A Randomized, Single-Blind, Parallel-Group, Multicentre Study

By Kelly Sue  

Clinical Drug Investigation, Vol. 30, Iss. 5, 2010-05 ,pp. : 325-336

Adis International

Access to resources Recommend Favorite

Preparation, Characterization, and Bioavailability of Ursodeoxycholic Acid-Phospholipid Complex In Vivo

By Yue Peng-Fei   Yuan Hai-Long   Xie Huan   Xiao Xiao-He   Yang Ming   Liao Mei-Xiang   Zhu Wei-Feng   Cai Pei-Lie  

Drug Development and Industrial Pharmacy, Vol. 34, Iss. 7, 2008-07 ,pp. : 708-718

Informa Healthcare

Access to resources Recommend Favorite

Effects of Oral Contraceptives on the Pharmacokinetics of Moxifloxacin in Premenopausal Women

By Shain C.S.   Whitaker A-M.   Amsden G.W.  

Clinical Drug Investigation, Vol. 22, Iss. 7, 2002-07 ,pp. : 429-434

Adis International

Access to resources Recommend Favorite